CIBC Private Wealth Group LLC Sells 519 Shares of Humana Inc. (NYSE:HUM)

CIBC Private Wealth Group LLC reduced its holdings in Humana Inc. (NYSE:HUM) by 23.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,728 shares of the insurance provider’s stock after selling 519 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Humana were worth $463,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. HighTower Advisors LLC raised its holdings in Humana by 2.1% during the 3rd quarter. HighTower Advisors LLC now owns 8,992 shares of the insurance provider’s stock worth $2,852,000 after buying an additional 187 shares during the period. IHT Wealth Management LLC raised its holdings in shares of Humana by 38.2% during the third quarter. IHT Wealth Management LLC now owns 1,082 shares of the insurance provider’s stock worth $334,000 after acquiring an additional 299 shares during the period. Royal London Asset Management Ltd. lifted its position in Humana by 2.1% in the 3rd quarter. Royal London Asset Management Ltd. now owns 65,957 shares of the insurance provider’s stock valued at $20,891,000 after acquiring an additional 1,347 shares in the last quarter. Quarry LP boosted its stake in Humana by 862.9% in the 3rd quarter. Quarry LP now owns 337 shares of the insurance provider’s stock worth $107,000 after purchasing an additional 302 shares during the period. Finally, Stifel Financial Corp increased its holdings in Humana by 8.8% during the 3rd quarter. Stifel Financial Corp now owns 59,432 shares of the insurance provider’s stock worth $18,825,000 after purchasing an additional 4,804 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

Shares of HUM stock opened at $253.37 on Friday. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a market capitalization of $30.58 billion, a price-to-earnings ratio of 25.46, a PEG ratio of 2.05 and a beta of 0.62. The company has a 50-day simple moving average of $267.58 and a 200 day simple moving average of $271.85. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Truist Financial upped their price target on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Piper Sandler increased their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Finally, StockNews.com lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th. Eighteen analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus target price of $280.17.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.